New research at Wake Forest University School of Medicine suggests that certain inhaled asthma medications ? as well as similar chemicals our bodies produce during times of high stress ? may worsen diseases such as asthma, heart failure and lupus that involve inflammation.
The news that the world’s first targeted therapy, trastuzumab (Herceptin), is now available for many women with early-stage HER2-positive breast cancer “highlights a truly significant advance in the management of breast cancer,” says Edith Perez, M.D., director of Mayo Clinic’s Breast Clinic in Jacksonville, Fla.
The Nuffield Council on Bioethics has set out guidelines on when to give intensive care to extremely premature babies. Advice for parents and doctors is provided, on a week-by-week basis, for treating babies born before 22 weeks up to those born after 25 weeks.
Fighting like a girl or fighting like a boy is hardwired into fruit fly neurons, according to a study in the November 19 Nature Neuroscience advance online publication by a research team from Harvard Medical School and the Institute of Molecular Pathology in Vienna. The results confirm that a gene known as “fruitless” is a key factor underlying sexual differences in behavior.
Pledging his eyes, Health Minister Anbumani Ramadoss today said that the country India hoped to achieve its target of vision to all by the year 2015.
Most students from California are too big, too slow and too weak, according to the results of the state’s annual fitness test released Friday.
The Mentor MemoryGel? Silicone Gel-Filled Breast Implant is a silicone shell filled with silicone gel. The implants are available with textured and smooth surfaces and with various profiles and sizes.
The Inamed? Silicone-Filled Breast Implant is a silicone shell filled with silicone gel. The implants are available with textured and smooth surfaces and with various profiles and sizes.
The U. S. Food and Drug Administration (FDA) today expanded the approved use of Herceptin, a biological cancer drug. The new indication is for Herceptin, in combination with other cancer drugs, for the treatment of HER2 positive breast cancer after surgery (lumpectomy or mastectomy). FDA granted priority review to the supplemental application for Herceptin.
After rigorous scientific review, the U.S. Food and Drug Administration (FDA) today approved the marketing of silicone gel-filled breast implants made by two companies for breast reconstruction in women of all ages and breast augmentation in women ages 22 and older. The products are manufactured by Allergan Corp. (formerly Inamed Corp.), Irvine, Calif., and Mentor Corp., Santa Barbara, Calif.